X
Please Wait
Applying Filters...
01 JANSSEN PHARMS (5)
01 TABLET, ORALLY DISINTEGRATING;ORAL (5)
01 DISCN (5)
01 RISPERDAL (5)
01 Yes (5)
19
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RISPERIDONE, with a corresponding application number 21444.
Regulatory Information DISCN
With a dosage strength 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2003-04-02
18
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RISPERIDONE, with a corresponding application number 21444.
Regulatory Information DISCN
With a dosage strength 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2004-12-23
17
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RISPERIDONE, with a corresponding application number 21444.
Regulatory Information DISCN
With a dosage strength 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2003-04-02
16
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RISPERIDONE, with a corresponding application number 21444.
Regulatory Information DISCN
With a dosage strength 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2004-12-23
15
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RISPERIDONE, with a corresponding application number 21444.
Regulatory Information DISCN
With a dosage strength 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2003-04-02
Market Place
